Ustekinumab infusion to subcutaneous transition: Coordinating care and identifying potential gaps
Ustekinumab initiation and escalation within the first year can be a complex process requiring a high level of care coordination to ensure patients receive timely therapy while reducing potential waste.
Authors
- Chelsea P. Renfro (ORCID: https://orcid.org/0000-0002-4090-8457)
- Miranda Kozlicki
- Autumn D. Zuckerman (ORCID: https://orcid.org/0000-0002-8376-0691)
- Leena Choi (ORCID: https://orcid.org/0000-0002-2544-7090)
- Josh DeClercq (ORCID: https://orcid.org/0000-0002-8171-5766)
- Patrick Nichols
- Jessica Fann
- Rachael D. Baggett
Institutions
- University of North Carolina Hospitals (US)
- Vanderbilt Health (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-07-24
- DOI
- https://doi.org/10.18553/jmcp.2025.31.8.764
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00